Print Page     Close Window     

SEC Filings

AC IMMUNE SA filed this Form 20-F on 03/21/2019
Entire Document

Convertible Note Agreement | AC Immune SA, 11 December 201817/23






Eli Lilly and Company
As the Lender



  /s/ David A. Ricks    
  Name: David A. Ricks    
LML Function: Chairman, President and Chief Executive Officer    






AC Immune SA

As the Borrower or the Company


  /s/ Andrea Pfeifer   /s/ Martin Velasco
  Name: Andrea Pfeifer   Name: Martin Velasco
  Function: Chief Executive Officer   Function: Chairman




© AC Immune 2015